Skip to main content
. 2021 Apr 7;13(8):1755. doi: 10.3390/cancers13081755

Table 1.

Patient characteristics. The p-values related to age are calculated by T-test (columns 5 and 6, marked in italics). The other group comparisons of columns 5 and 6 were performed with two-sided Fisher’s exact test. Values statistically significant at the 5% significance level are marked with *. Abbreviations: − = negative, + = positive, chemo = chemotherapy, IQR = interquartile range, RT = radiotherapy.

Patient Characteristics 1 2 3 4 5 6
Total HPV+ Nonsmokers HPV+ Smokers HPV− Patients p-Values HPV+ vs. HPV− (n = 57 vs. n = 34) p-Values Smokers vs. Nonsmokers (n = 69 vs. n = 22)
n = 91 n = 20 n = 37 n = 34
Age at diagnosis of index tumor Median (y) 59.54 58.2 58.7 57.6 0.483 0.646
IQR 52.7–65.6 52.8–66.7 51.0–67.3 53.8–65.1
Sex
male n (%) 68 (74.7%) 14 (70%) 28 (75.7%) 26 (76.5%) 0.809 0.413
female n (%) 23 (25.3%) 6 (30%) 9 (24.3%) 8 (23.4%)
History of alcohol abuse n (%) 28 (30.8%) 0 9 (24.3%) 19 (55.9%) 0.000 * 0.000 *
Index-OPSCC
localization
Tonsils n (%) 79 (86.8%) 19 (95%) 34 (91.9%) 26 (76.6%) 0.050 * 0.281
Base of tongue n (%) 9 (9.9%) 1 (5%) 3 (8.1%) 5 (14.7%) 0.286 0.446
Soft palate n (%) 1 (1.1%) - - 1 (2.9%) - -
Pharyngeal wall n (%) 2 (2.2%) - - 2 (5.9%) - -
Death due to OPSCC or associated cancer n (%) 17 (18.7%) 2 (10%) 5 (13.4%) 10 (29.4%) 0.054 0.226
Index-UICC stadium
I n (%) 15 (16.5%) 3 5 7 0.56 1
II n (%) 17 (18.7%) 5 6 6 1 0.345
III n (%) 11 (12.1%) 0 4 7 0.093 0.06
IVa n (%) 47 (51.6%) 12 22 13 0.055 0.47
IVb n (%) 1 (1.1%) 0 0 1 - -
Treatment
Surgery n (%) 91 (100%) 20 (100%) 37 (100%) 34 (100%) 1 1
RT ± chemo n (%) 60 (65.9%) 13 (65%) 25 (67.6%) 21 (61.8%)